Health Archive » March, 2026

Health - March, 2026

415 articles

• State Privacy Enforcers Broadening Work As Resources Grow
• 'Best Judicial System In The World': Alsup Reflects On Career
• Split 4th Circ. Affirms Injunction On W.Va. Drug Discount Law
• Novartis Seeks To Block New Wash. 340B Drug-Pricing Law
• Novartis Can't Nix FCA Suit Alleging MS Drug Kickbacks
• 5th Circ. Grills Fraudsters Over $158M Healthcare Scheme
• Anesthesia Parent Can't Duck Antitrust Suit, But Affiliate Can
• Goodwin-Led Whoop Raises $575M At $10B Valuation
• Full Fed. Circ. Is Told Panel Defied EcoFactor In DePuy Case
• SEIU Arbitration Suit Strains Order, Hospital Says
• Telemedicine Biz Can't Escape Investor Suit Over User Losses
• Ill. Panel Says No Error In Doc's Nerve Damage Suit Win
• Big Insurers Must Face 'Repricing' Antitrust Claims
• Mich. Judge OKs Bias Training For Healthcare Workers
• Biogen Paying $5.6B For Apellis As 4 Firms Advise
• Berk May Spur More Pushback Against Med Mal Gatekeeping
• Pot Opponents Seek To Block CMS Hemp Benefit Program
• Verdicts Signal Product Liability's Expansion To Digital Realm
• Insurer Says Yale Was 'Misleading' In $4.1M Transplant Claim
• Kirkland, Goodwin Steer Lilly $7.8B 'Sleep-Wake' Disorder Deal
• Nurses Union Can't Force Arbitration, Mich. Hospital Says
• Getting The Most Out Of Learning And Development Programs
• OhioHealth Suit Signals Higher Antitrust Heat On Hospitals
• A Shift In Fed. Circ.'s Approach To Patent Summary Judgment
• Justices Reject Colorado's LGBTQ+ 'Conversion' Ban
• Minn. Panel Says Med Mal Experts Wrongly Axed, Revives Suit
• 5th Circ. Seems Open To Reviving Eyemart Class Action
• Don't Set Special IP Rules For 'Skinny Labels,' Justices Told
• Fla. Hospital System Patients Get Class Cert. Denied
• Foreseeability 'Tricky' For Yale Doc's 1981 Act, Court Told
• Product Liability Q1 Regulatory Roundup
• FCA Qui Tams Are Unconstitutional, Eli Lilly Tells Justices
• 5th Circ. Calls Pharmacy GLP-1 Args 'Tough Pills To Swallow'
• Eye Doctor Appeals Microcaptive Tax Payments At 5th Circ.
• Steward Health Creditor Trustee Sues Aetna For $6.4M
• FTC Says Anesthesia Group Cheered While Raising Prices
• Cleary-Led Blackstone Wraps Record $6.3B Life Sci Fund
• Eli Lilly's $2.75B Pact Is Latest In AI Drug Discovery Push
• TriZetto's $70M Trade Secret Verdict Upheld, Total Award Cut
• J&J Unit Wants Forensic Exam Of Ex-Director's Devices
• Del. Blackbaud Ruling Signals A New Era For Cyberinsurance
• AI Presents A Make-Or-Break Moment For Outside Counsel
• Justices Pass On FCA Suit Alleging Quest Diagnostics Fraud
• Justices Reject TM Appeal Tied To 'Use In Commerce'
• Elizabeth Holmes Gets 11-Year Prison Sentence Cut By A Year
• Eye Clinic's Hurricane Damage Suit Sent To Territorial Court
• Eli Lilly Keeps Most Of Weight Loss Drug Copy Suit Alive
• NC Biz Court Bulletin: Judge Exits, Duke Ducks Climate Suit
• 5th Circ. Won't Revive Ex-Health IT Co. Worker's Bias Suit
• Hospital System Beats Most Of REIT's $50M Floodwall Suit
• Skincare Co. Says ITC Ruling Backs Ending PTAB Challenge
• Sens. Push Bill To Equip VA For Psychedelic Therapies
• DOJ Actions Suggest Expansion Of Healthcare Enforcement
• Biopharma's Brass Hid Anxiety Drug Trial Risks, Investor Says
• States Suspect ICE Obtained Medicaid Data Despite Order
• Biogen Beats Investor Suit Over Dozens Of Drug Claims
• Mississippi Gov. Vetoes Medical Marijuana Expansion Bill
• Pa. Health Network's $1.15M 401(k) Suit Deal Gets Final OK
• Insurer Rips Sanctions Bid In Opioid Coverage Dispute
• Colo. Nurses Snag Class Cert. In Holiday Pay Case
• Hospital Escapes Ex-Workers' 401(k) Forfeiture, Fund Suit
• Kirkland-Led Transcend Bought By Otsuka In $1.2B Deal
• Watching Hallmark Movies Makes Me A Better Lawyer
• Ex-Mich. City Workers Say Judge Erred In Trimming Vax Suit
• Imaging Practice Data Breach Class Actions Hit NC Biz Court
• Co. Accused Of Sharing Mental Health Data With Google
• Legislative Update: Cannabis And Psychedelics Bill Roundup
• Pregnancy 'Crisis' Center Loses Bid To End Deception Claims
• Texas Court Won't Dismiss Patient's Cancer Misdiagnosis Suit
• McDonald Hopkins Must Produce Fraud Warning Docs
• U.S. Lawmakers Renew Tribal Child Abuse Prevention Bill
• DOJ Says NY-Presbyterian Blocked Lower-Cost Health Plans
• 9th Circ. Upholds Medtronic Win In Spinal Cord Device Suit
• Regeneron Can't Sink Disability Bias Claims Over Scheduling
• IOC Bans Transgender Athletes From Women's Competitions
• Law Firm Ransomware Attacks On Rise, Report Says
• AbbVie, Novartis Sue Wash. Over New 340B Drug-Pricing Law
• Medical Cannabis Co. Seeks Win In Spam Text Suit
• Ex-Pharma GC Freed From Trade Secrets Suit Amid Ch. 7 Stay
• Calif. Tribe Says IHS Compact Delay Risks More Opioid Deaths
• 3rd Circ. Probes Free Speech Impact Of NJ Telemedicine Law
• Co.'s Dual Citizenship Doesn't Kill Jurisdiction, 4th Circ. Told
• Insurers, Brokers Can't Exit Medicare Advantage Steering Suit
• DOJ Defends FCA's Qui Tam Constitutionality At 5th Circ.
• Paragon 28 Beats Investor Suit Over Inventory Accounting
• PBMs Say Mich. Price-Fixing Suit Lacks Specifics
• McKesson Accuses Former Exec Of Leaking Trade Secrets
• New Orphan Drug Law Provides A Key Fix For Pharma Cos.
• Mom Tying Abbott Formula To Baby's NEC Takes The Stand
• Full Fla. Panel Says Teacher Filed Timely Injury Benefits Claim
• Foreign Aides' RICO Labor Suit Against PruittHealth Hits NC
• Insurer Need Not Cover Parkinson's Drug Antitrust Dispute
• Jury Doubles Damages Against Meta, Google In LA Bellwether
• Covington, Freshfields Advise On $6.7B Merck Oncology Deal
• Trump Admin Settles Suit Over Biden Social Media Collabs
• Immigrant Minors Seek End To Repeat Sponsor Checks
• Drug Co. Atara Hit With Investor Suit Over FDA Denial
• Biz Services Co. Faces ERISA Suit Over 'Tobacco Surcharge'
• Judge Trims DEA's Suspension Of Fla. Pharmacy's Permits
• Fla. Judge Tosses Fired Reporter's Vaccine Suit Against PGA
• FTC Rejects Bids To Block Gender-Affirming Care Probe
• Treating Doc Can Opine On Nurses In Texas Spine Surgery Suit
• FDA User Fee Talks Offer Clues On Upcoming Reforms
• $5.7M Cigna Ghost Network Deal Receives Final Go-Ahead
• Genesis Gets OK For $7.3M Employee Bonus Plan
• Changes Coming To The SBIR And STTR Programs
• Clark Hill Says No Conflict Exists In Health Noncompete Fight
• Health Co. Escapes Workers' 401(k) Forfeiture Suit In La.
• 6 Firms Guide Gilead's $2.2B Autoimmune Drug Play
• FTC To Mull Caremark Deal In PBM Insulin Pricing Case
• Ohio Justices Likely Split On Trans Care Restrictions
• Fraud Task Force May Boost White Collar Defense Work
• Justices Won't Review Class Cert. In Diabetes Drug Risk Case
• Mass General Accused Of Shaving Time From Workers' Pay
• CooperSurgical Fights Docs Request In Embryo Loss Suit
• Emory Healthcare Defeats Black Nurse's Retaliation Suit
• Stem Cell Clinic Accused Of Deceiving Patients
• Nursing Home Atty Fees Axed Over Lack Of Proximate Cause
• FTC Stays Focused On Healthcare, Launches Task Force
• Novartis Faces Class Suit Over Patient Health Info Disclosure
• Md. Judge Rules Written Consent Not Needed Under TCPA
• Pediatric Data Breach Class Action Can Stay In NC Biz Court
• Injury Law Roundup: Meta Atty Uses Jane Doe Plaintiff's Name
• Progressive Escapes Workers' Tobacco, Vaccine Fee Suit
• Duke Health's $3.7M Pixel Privacy Deal Gets Initial OK
• Healthcare Co. Liable For Patient's Killings, Philly Jury Told
• Feds Approve Minnesota's Plan To Combat Medicaid Fraud
• Health Insurers Can't Force Conn. ERISA Row Into Arbitration
• AbbVie Escapes Ill. Genetic Privacy Lawsuit
• High Court Won't Hear Mich. Newborn Blood Testing Case
• Sidley, Kirkland Steer $1.1B Sale Of EyeSouth's Retina Biz
• Trinity, Health Gorilla Sued Over Patient Data Breach
• Justices Won't Review Lab Owner's Kickback Conviction
• High Court Won't Hear Calif. Border Hospital Medicaid Fight
• Justices Pass On Challenge To Courts' Sanctions Authority
• Feds Rip Ex-NFL Player's New Trial Bid Over Medicare Scheme
• Former Gilead Sciences GC To Earn Over $2.5M Severance
• CytoDyn Settles Investor Suit With $500K, 49M Shares
• EPA's Ethylene Oxide Plan May Hinder Other Air Toxics Regs
• Expert's Conflicting Testimony Dooms Med Mal Case In NJ
• Eli Lilly Beats 9th Circ. Appeal Over Brain Bleed After Cialis
• Pa. Hospital Must Pay $109M For Brain Injury During Birth
• IVF Patients Say Co. Misled Them On Genetic Test's Accuracy
• FDA Framework For Personalized Therapies Raises Questions
• Hims Says Failed Wegovy Collab Doesn't Merit Investor Suit
• 5 Tips For Navigating Your Firm's All-Attorney Summit
• Vein Restoration Co. Will Pay $4M To End False Claims Suit
• Mich. BCBS Unit Gets Health Plans' Claims Fight Transferred
• 3 Firms Pilot Senior Housing REIT Janus Living's $840M IPO
• Eye On ERISA: A Chat With King & Spalding's Darren Shuler
• Prestige Picks Up Breathe Right In $1.05B Deal
• 4th Circ. Leery Of W.Va. Opioid Towns' Abatement Arguments
• HHS Can't Block Trans Care Under Kennedy Edict, Court Says
• Pharma Group Can't Halt Colo. Law Over Drug Discount Rules
• Legislative Update: Cannabis And Psychedelics Bill Roundup
• 11th Circ. Partially Reopens Aetna Twin Birth Coverage Fight
• Drug Co. Can't Claim Most Docs Contain Trade Secrets At Trial
• $30K Wage Settlement Too Vague To Approve, Judge Says
• Calif. Families Sue Rady Health Over Move To End Trans Care
• Maya Kowalski Says Atty Made Her 'Uncomfortable'
• Fla. Court Won't Pause Restoration Of Medicaid Benefits
• Goodwin, S&C Steer Up To $785M Sale Of ADHD Drug
• TriZetto Wants To Expand IP Claims Against Infosys
• Scrutiny Of Nursing Home Practices Marks Inflection Point
• Detroit Clinic Zones Impede Free Speech, Protesters Say
• CVS, Caremark Pocket Money Meant For Rebates, Suit Claims
• Ohio Home Health Co. Settles OT Suit For $975K
• Univ. Of Colorado Health Seeks Dismissal Of Wage Suit
• Zynex Gets OK For Ch. 11 Plan Reducing Debt By $50M
• Coaching Soccer Makes Me A Better Lawyer
• Key Details As 3rd Circ. Ponders FCA's Fate, $1.6B J&J Fine
• Zuckerberg, Snap CEO Likely Must Testify In School MDL Trial
• Stryker Hit With Another Suit After Cyberattack
• SelectQuote Looks To Escape Investors' Kickback Probe Suit
• UnitedHealth Customers Denied Class Cert. In PrEP Suit
• Ed. Dept. Flouting Mental Health Funding Order, States Claim
• Texas Panel Says Doc Can't Block Report Of Suspension
• Split 2nd Circ.: NY Officials Belong In Inmate Mental Health Suit
• WWE Accuser's Ex-Doctor Questions Motive For Records Bid
• CNA Unit Seeks To Enter Wrongful Death Coverage Dispute
• Doctor Gets 6½ Years For Healthcare Fraud, Tax Evasion
• Philips, Fitbit End Fight Over Health Monitoring Patents
• ADA Challenge to Oregon Psilocybin Law Can Proceed
• Law School's Missed Lessons: The Human Element
• Health Litigator Rejoins Holland & Knight From In-House Role
• 9th Circ. Backs Rare FCA Theory In Huge Drug Prices Program
• Dr. Oz Claims Florida Also Has Healthcare Fraud Problem
• Geico Keeps RICO, Fraud Claims In NY No-Fault Billing Suit
• Union Health Fund Wins $3.5M Debt Litigation Against Suit Co.
• House Panel Advances Bill Aimed At Curbing ERISA Litigation
• Ex-Database Administrator Settles OT Claim
• Bipartisan Bill To Waive $100K H-1B Fee Gets AMA Backing
• SEIU Pension Fund Wins $842K Suit Against NJ Nursing Home
• 9th Circ. Says Idaho Doc Must Face Wash. Fatal Overdose Suit
• Medical Goods Co. Can't Appeal Insurance Reimbursement
• Alcon Drops $430M Lensar Deal Under Pressure From FTC
• Drug Developer GNQ To Go Public Via $500M SPAC Deal
• CMS Healthcare Enforcement Initiatives May Cause Disruption
• Apple Can't Shake Most PFAS Claims In Smartwatch Suit
• McGuireWoods Adds Former CDC Scientist From McDermott
• Fenwick Healthcare Regulatory Atty Rejoins Latham In LA
• PBGC Keen On Dishing Out Opinion Letters, Director Says
• 1st Circ. Affirms Block Of Trump's 'Unprecedented' Aid Freeze
• Md. Appeals Court Upholds Ax Of MedStar Data Sharing Suit
• Trump Taps Vance For Fraud Task Force, Bashing Blue States
• Trump Admin Wants Student Loan Forgiveness Suits Tossed
• Defamation Suit Against WWE Accuser's Lawyer Advances
• Judge Tosses Kaiser Whistleblowers' Claims After $556M Deal
• Pa. Appeals Court Reinstates Kratom And Caffeine DUI Charge
• J&J's Lack Of Malice Gets $966M Talc Verdict Cut To $16M
• Mich. Jury Awards $10M To Med Resident Fired During Leave
• Medtronic Seeks To Ax 'Extreme Outlier' $382M Antitrust Loss
• How Cos. Should Prepare For NY RAISE Act Compliance
• HHS' Childhood Vaccine Policy Changes Put On Ice
• What We Know About DOJ's New FCA Enforcement Priorities
• Incentive Pay Boosted Cigna GC To $5.96 Million In 2025
• The Benefits Of Choosing A Niche Practice In The AI Age
• GAO Rejects Unequal Evaluation Claim In CMS Contract
• Triton Clinches €5.5B For 6th Fund In Largest Raise To Date
• Senior Housing REIT Janus Living Seeks $703M From IPO
• Mass. City Accused Of Bias In Mental Health 911 Response
• 'Swinging Dicks' Dissent Stirs Uproar Across 9th Circ. Bench
• Cannabis Co. Loses Bid To Merge Rival's Suit With AI Fight
• Maryland Bros. Get Prison For HIV Drug Fraud Scheme
• 4th Circ. Brings Back Allergan Medicaid Overcharging Suit
• How PBMs Can Adapt To Plan Sponsors' Disclosure Demands
• Conn. Statehouse Catch-Up: AI, Social Media, Private Equity
• Sandoz Appealing Ruling Over Amgen's Enbrel Biosimilar
• Voyager Acquisition's 2nd SPAC Seeks To Raise $220M
• Texas Justices Clear Way For State's Trans Care Probe
• Kroger Agrees To Pay $17M In Drug Copay Inflation Case
• J&J Unit Says Ex-Director Misappropriated Trade Secrets
• UK Litigation Roundup: Here's What You Missed In London
• Drug Co. Moves To Sanction Insurer Over Destroyed Evidence
• EPA Aims To Lift Biden-Era Ethylene Oxide Limits
• Tort Report: Uber Won't OK Bigger Jury At 2nd Bellwether
• Ariz. Docs Ink $4.75M FCA Deal Over Unnecessary Treatment
• Top Texas Court Upholds Death Sentence For ICU Nurse
• DC Circ. Spends Hours Debating 'Same' Generic Label Reqs
• Wash. Justices OK Jury Instruction In TB Malpractice Case
• Colo. Panel Clarifies Workers Comp Law On Maintenance Care
• Insurer Asks NC Justices To Free It From Captive Carrier Row
• Embryo Loss Suits Need 'Serious' Edits, Judge Told
• Meta To Face Sanctions Bid Over Addiction MDL Privilege Log
• US Chamber Report Warns Of Risks To IP Protection
• Idaho Says Director Immune In THC Child Abuse Registry Suit
• NFL Alumni Argues Biotech's Suit Lacks Contractual Basis
• How To Engage With Gov't's Direct-To-Consumer Drug Policy
• Doc's Hands Aren't Property, Texas Panel Rules In Death Suit
• It's Time To Clarify California's Elder Abuse Act
• Podcasting Makes Me A Better Lawyer
• DNA Testing Co. Can't Shake Suit Over Genetic Data Sharing
• Eli Lilly Ordered To Arbitrate Alzheimer's Drug Feud
• New Wyoming Abortion Law Faces Familiar Legal Challenge
• La. Fights Dismissal Bid In Abortion Regulation Dispute
• Ohio Hospital Defeats DaVita's Dialysis Discrimination Suit
• Wash. Says ICE Contractor Cannot Defend Barring Inspection
• Allstate Says Chiropractors Ran 'Personal Injury Mill'
• Insulin Makers Ask Justices To Review Collusion Case
• Pharma Co. Says Ex-Director Using Trade Secrets At New Job
• VA, DOJ Cut Deal To Make Attys Mental Health Guardians
• Pa. Justices Hint 3rd Jury Should Decide Misdiagnosis Case 
• Pa. Justices Doubtful Law Unclear In AG-DA Opioid Deal Row
• Minn. Lawmakers Advance Medical Psilocybin Bill
• SEC Avoids Sanctions As Court Ends Unregistered Dealer Suit
• Union Claims NJ Hospital Broke State Law In Layoffs
• Biomedical Co. Settles Trade Secrets Case Against Ex-Worker
• When Fraud Involvement Disqualifies FCA Whistleblowers
• Job Shift Accommodation Ruling Clarifies 'Essential Function'
• Coalition Pushes For Ruling To Nix State Dept. Visa Pause
• Hospital Revenue Co. Not Covered In $8M Loss Suit, AIG Says
• 6th Circ. Upholds Ax Of Hospital Security Guard's Wage Suit
• Aetna Will Pay $117.7M To Resolve False Billing Suit
• Wash. Justices Seem Open To Palestinian's Racial Bias Claim
• UnitedHealth Must Reveal Nitty-Gritty In Claim Denial AI Case
• Sanofi Says Judge Botched Insulin Device Patent Listings
• Lab's Aetna Payment Suit Survives, But With Deep Cuts
• FDA To Consider Coffee, 'Spice' E-Cig Flavors
• Wash. To Set Its Own Vaccine Schedule Under New State Law
• Fed. Circ. Must Bury Design Patent Doctrinal Zombies
• 4th Circ. Backs W.Va.'s Trans Care Coverage Exclusion
• CVS Can't 'Relitigate' Price-Gouging Class Cert.
• 2nd Circ. Revives Geico's Suit Over Acupuncture Referrals
• H-1B Registration Tips For New Wage-Weighted Selection
• Lessons From Justices' Split On Major Questions Doctrine
• Liberty Mutual Says Mich. Clinics Ran RICO Billing Scheme
• Former Conn. Prosecutor Can Stay On Generic-Drug Case
• Medtronic Expands Vascular Device Line With $550M Deal
• Drug Wholesaler's DPA Shows Imperfect Efforts Still Count
• AFSCME Sues Trump Admin Over $600M Health Funding Cuts
• Judge Urges Resolution In NY Nursing Home Ch. 11
• Fla. Judge Finds Leapfrog's Hospital Ratings Deceptive, Unfair
• Texas AG Gets Temporary Ban On Chest Binder Sales
• Vehicle Manufacturer Strikes Deal In Tobacco Surcharge Suit
• Abbott Formula Linked To 'Horrible' Gut Disease, Ill. Jury Told
• Abortion Rights Group, SD Agree to End Gas Station Ads Row
• Verano Receipts Out Medical Pot Users, Suit Claims
• Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together
• Biopharma Brass Hid Drug Trial Risks, Derivative Suit Says
• Key Takeaways As HRSA Aims To Revive 340B Rebate Pilot
• DC Circ. Skeptical That Review Of $100K H-1B Fee Is Foreclosed
• McGuireWoods Beats Sun Pharma's DQ Bid In NJ Suit
• 3 Convicted Of Using Dental Practice To Defraud Medicare
• 3 Firms Advise On Talkspace's $835M Planned Sale To UHS
• NC Providers Sue UnitedHealth Over 'Devastating' Cyberattack
• Mammogram Provider To Pay $2.5M Over Data Breach
• Trans Patients Score Block On Aetna Facial Surgery Exclusion
• Sullivan & Cromwell Advises Agilent On $950M Biocare Buy
• JPMorgan Trims But Can't Escape ERISA Drug Costs Suit
• Atty Should've Checked Docket, Says Philips CPAP Judge
• ExThera Exec Hid Patient Deaths To Keep $10M Deal, DOJ Says
• Health Groups Back Bid To Bar Noncitizen Benefit Restrictions
• FDA Vaccine Chief Prasad To Exit Agency For 2nd Time
• DC Circuit To Hear Appeal On Idaho Abortion Law Subpoena
• 9th Circ. Mulls Whether Politics Tainted DOJ Trans Care Probe
• Boston Scientific Investor Sues Over Growth Projections
• Mass. Judge Told Vax Committee Must Be Fairly Balanced
• TriZetto, Cognizant Hit With Class Claims Over Data Breach
• Care Co. Automatically Deducted Meal Breaks, Suit Says
• Constantine Cannon Defends Handling Of Sutter $75M Fee
• Sanofi Selling Medley Unit To Brazilian Drug Co. For $500M
• Express Scripts Ducks RICO Suit Over Acthar Price Hike
• Dentist Says She Was Fired For Exposing Medicaid Fraud
• Pa. High Court Snapshot: AG Powers, Gun Parts, CEO Bonus
• Baker McKenzie Guides Servier On $2.5B Oncology Deal
• UK Litigation Roundup: Here's What You Missed In London
• Nurses' Holiday Pay Suit Against Health System Trimmed
• Cleary, Davis Polk Lead Diabetes Biz MiniMed's $560M IPO
• Telehealth Co. Swaps In Gordon Rees In Novo's GLP-1 Fight
• A Look At Four States' Tort Reform Legislation Fights
• Ind. Justices Reverse Providers' Loss In COVID Immunity Row
• 9th Circ. Denies Bail Pending Nurse Wage-Fixing Appeal
• Progenity Investors' $1M Billing Fraud Suit Deal Gets Final OK
• 9th Circ. Judge 'Frustrated' At DOJ Position On Anti-Trans EOs
• GAO Denies Protest Of $325M CDC Contract
• Why Mukherji Won't End USCIS' EB-1A Two-Step
• Unique Issues Facing Brand-Compounder Patent Litigation
• ApolloMD Reaches $4M Deal To End Data Breach Claims
• Ex-Conn. Hospital Worker Drops Suit Over Post-Assault Firing
• Minn. Man Gets 5 Years For Jury Rigging In Fraud Case
• 5th Circ. Upholds $919K Fee Award In Overtime Suit
• Polsinelli Brings On McDermott Healthcare M&A Pro In Florida
• Senior Living, Nursing Platform Sage Raises $65M In Series C
• BCBS Can't Nix NC Plan Member From Cancer Treatment Row
• Doctor Can't Fight Records Order Tied To WWE Accuser's Suit
• ERISA Recap: 6 Developments To Remember From Feb.
• Fla. Lab Pays $980K To Settle Kickback Allegations
• Insurer Seeks Win In $6.3M Coverage Row With Pot Tester
• Volunteering With Scouts Makes Me A Better Lawyer
• Wheeling & Appealing: The Latest Must-Know Appellate Action
• CVS Beats Antitrust Suit Over 340B Drug Program, For Good
• Panel Backs NJ Corrections In Trans Woman's Transfer Bid
• Colo. Court Weighs Nursing Facility $6.7M Indemnity Ruling
• Okla. Judge Lets Pot Grower Save Plants Amid Dispute
• Care Management Co. Accused Of Swiping Software Platform
• Ill. Health System Can Take Privacy Case To 7th Circ.
• Trump's FCA Expansion Plan Heightens Compliance Risk
• Regeneron, Sanofi Didn't Warn About Cancer Risk, Suit Says
• Doctor's Firing Dispute Belongs In Arbitration, Fla. Court Says
• 9th Circ. Hesitant To Revive Implant Suit Against Medtronic
• 5th Circ. Leery Of Tossing Doc's Conviction In $84M Scheme
• DC Judge Strikes Down 340B Drug Discount Registration Rule
• Fla. Hospital, EMT Beat Suit Over Unauthorized Trauma Photo
• Law School's Missed Lessons: In Court, It's About Storytelling
• Pros And Cons Of FDA's Push For Nonprescription Drugs
• Select Medical's $3.9B Deal Is Latest Insider-Led Buyout
• BakerHostetler Aided Illegal Insurance Scheme, Trustee Says
• Sandoz Parent Targets Walmart, Southwest Generic Drug Suits
• 6th Circ. Backs Tenn. Med School In FMLA Retaliation Suit
• Buyers Finalize $58M Generic-Pricing Deal With 3 Drugmakers
• NY Bill Would Expand Liability For Chatbot Operators
• Judge Sets 'Hard Deadline' To Rule On Childhood Vax Policy
• House Panel Tussles Over Minnesota Medicaid Fraud Claims
• 7th. Circ. Upholds Healthcare Co.'s Win In FMLA Suit
• Medical Pot Co. Can't Escape Guarantor Status In Lease Fight
• Gordon Rees Opens New Offices In North Carolina, Wisconsin
• 11th Circ. Backs Dismissal Of Fee Dispute From BCBS MDL
• Inova Defeats Nurses' COVID Vax Bias Suits At 4th Circ.
• Death From Stem Cell Treatment For ALS Draws $24M Verdict
• Ex-FDA Leaders Rebut Contraception Rollbacks At 3rd Circ.
• FDA Targets Advertising For Knockoff Weight-Loss Meds
• NC Doctor's Bid For New Trial Is Too Late, Judge Says
• Florida Man Pleads Guilty In $24M HIV Drugs Fraud Scheme
• Wells Fargo Escapes Ex-Workers' Prescription Cost Suit
• Prepping For The Future Of No Surprises Act Enforcement
• Monthly Merger Review Snapshot
• High Court's 'Skinny Label' Case May Tackle Wider Questions
• Aligning Microsoft Tools With NYC Bar AI Recording Guidance
• States Can't Duck Regeneron Counterclaims In FCA Case
• 4th Circ. Won't Revive Retired Miners' Health Fight
• Curaleaf Says No Private Info Leaked In Buyers' Data Suit
• Judge Won't Rely On DOJ 'Decency' In Trans Records Case
• 1st Circ. Won't Revive Boston's Opioid Claims Against PBMs
• FTC Makes 'Significant Progress' In OptumRx, Caremark Talks
• Fla. Billing Co. To Settle With Feds Over $15M Medicare Fraud
• High Court Blocks California's Gender Privacy Rule
• E-Rate Could Cut Some Regulatory Fat, FCC Told
• Texas AG Says Gender Care Ban Includes Mental Health
• Abbott Beats Data Sharing Suit Over Glucose Tracking Trial
• Epic Must Face Price Conspiracy Claims Over Gallstone Drug
• 3rd Circ. Unsure Criticism Of Prof's DEI Stance Is Defamation
• SEC Inks $200K Settlement In False PPE Press Release Suit
• Anthem Avoids Patients' Ghost Network Suit In NY
• NC Care Co. Operator Urges Judge To Ax Wage Verdict
• Class Actions At The Circuit Courts: March Lessons
• FDA's Biosimilarity Guidance Holds Uncertain Implications
• Unpacking Key Themes From NY's New Healthcare Strategy
• 6th Circ. Upholds 12-Year Stint For Mich. Doc In 'Pill Mill' Case
• 5 Different AI Systems Raise Distinct Privilege Issues
• Hagens Berman Denied Rehearing Bid In Sanctions Dispute
• Gyre, Cullgen Merge In $300M All-Stock Deal
• Physical Therapy Practice Owners Get 6 Years For Fraud
• Catching Up With Delaware's Chancery Court
• Drugmakers Warn Justices Oregon Pricing Law Risks Secrets
• Pepsi Extinguishes Employee's Tobacco Fee Lawsuit